Company / Operating Income per Share
Enveric Biosciences, Inc. Operating Income per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.22
FY2019
5-year range
-$4.22 / -$0.39
FY2017-FY2019
Trend
-603.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -604% YoY in FY2019, a notable deviation from the 2-year average annual change of -329%.
Based on SEC 10-K filings.
-4.22 in FY2019.
Declined from $-0.39 to $-4.22 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating income per share decreased 603.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$4.22 | -603.5% |
| FY2018 | -$0.60 | -54.9% |
| FY2017 | -$0.39 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026